Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now. |
Model Validation for Antiepileptogenic and Resistant Epilepsy Therapies
Release Date: August 21, 2003
Announcement Number: RFA-NS-04-002
Application Receipt Date:
November 21, 2003
Letter of Intent Date: October 21, 2003
Funding Contact: James Stables, MS Admin., R.Ph.
Program Area: Office of Translational Research
Brief Description:
Inviting applications to validate animal models of pharmacoresistant epilepsy or intervention in the epileptogenic processes
leading to chronic disease. The goal of this grant program is to validate proposed models of pharmacoresistant epilepsy and/or
antiepileptogenic models for use in drug discovery. It will establish baseline data and introduce new methods for evaluating
the therapeutic potential of novel compounds for the treatment of epilepsy.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |